ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 30916 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 30916; 2) Community: the network communities that were significantly associated with the response to NSC 30916; 3) Molecule: the relationships between components within communities and NSC 30916; 4) MDR: the compounds that were significantly associated with the NSC 30916.

NSC Compound Enrichment Correlation
NSC 718564 Null 0.0138010872611486 0.32942497
NSC 718781 Erlotinib hydrochloride 0.0138010872611486 -0.073710718
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0138010872611486 0.64148219
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0138010872611486 0.56522688
NSC 743694 Null 0.0138010872611486 0.68561266
NSC 744688 Null 0.0138010872611486 0.21087968
NSC 745449 Null 0.0138010872611486 0.68100653
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0138010872611486 -0.0077400968
NSC 752761 Null 0.0138010872611486 -0.13653472
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0138010872611486 0.13722843
Total:110  Current:37    [First] [Prev] [Next] [Last]